Simplify Asset Management Inc. Athira Pharma, Inc. Transaction History
Simplify Asset Management Inc.
- $2.46 Billion
- Q1 2025
A detailed history of Simplify Asset Management Inc. transactions in Athira Pharma, Inc. stock. As of the latest transaction made, Simplify Asset Management Inc. holds 1,492,792 shares of ATHA stock, worth $492,621. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,492,792
Previous 1,492,792
-0.0%
Holding current value
$492,621
Previous $880,000
52.61%
% of portfolio
0.02%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding ATHA
# of Institutions
61Shares Held
18.4MCall Options Held
14.3KPut Options Held
4.4K-
Perceptive Advisors LLC New York, NY5.4MShares$1.78 Million0.06% of portfolio
-
Bml Capital Management, LLC Zionsville, IN3.2MShares$1.06 Million0.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.54MShares$507,5110.0% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA1.49MShares$492,6210.49% of portfolio
-
Black Rock Inc. New York, NY676KShares$223,1600.0% of portfolio
About Athira Pharma, Inc.
- Ticker ATHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,817,700
- Market Cap $12.5M
- Description
- Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...